UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC
Position in BMRN — Biomarin Pharmaceutical Inc
CIK 861177
NEW YORK, NY
Position in BMRN
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$42,098,124
-$5,964,636 QoQ
Shares Held
735,724
-13.5% QoQ
Ownership
0.380%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#41
of 561 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 42%
Shared 0%
None 58%
Common Shares in BMRN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC holds $4,385,897,555 across 206 Biotechnology names. BMRN ranks #20 (1.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,086,683 | $1,533,248,041 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
716,560 | $446,803,817 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
727,848 | $219,104,078 | |
| 4 | INCY |
Incyte Corp
|
1,508,720 | $171,028,494 | |
| 5 | RVMD |
Revolution Medicines, Inc.
|
912,335 | $170,862,094 | |
| 6 | INSM |
INSMED Inc
|
1,335,071 | $142,345,265 | |
| 7 | IONS |
Ionis Pharmaceuticals Inc
|
1,454,672 | $115,340,938 | |
| 8 | MRNA |
Moderna, Inc.
|
1,521,849 | $106,575,080 |
All Filings in BMRN
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $42,098,124 | 735,724 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $48,062,760 | 850,819 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $37,959,422 | 638,725 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $58,177,204 | 1,074,173 | Shares | Other | 2025-11-14 | |
| 2025-06-30 | $72,548,960 | 1,319,792 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $75,279,469 | 1,064,924 | Shares | Defined | 2025-05-19 | |
| 2024-12-31 | $69,350,863 | 1,055,087 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $61,887,036 | 880,453 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $83,403,576 | 1,013,040 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $65,050,914 | 744,801 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $71,991,022 | 746,640 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $66,920,605 | 756,336 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $74,287,270 | 857,029 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $83,337,495 | 857,029 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $104,893,422 | 1,013,561 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $108,011,046 | 1,274,166 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $129,473,182 | 1,562,365 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $119,629,665 | 1,551,617 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $100,033,928 | 1,132,246 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $84,020,098 | 1,087,076 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $170,341,334 | 2,041,483 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $168,995,979 | 2,238,061 | Shares | Defined | 2021-05-14 | |
| 2020-09-30 | $153,496,265 | 2,017,564 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $144,162,749 | 1,168,824 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $110,372,884 | 1,306,188 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||